Export boost for Duopharma


Leonard Ariff: We are continuously looking to enhance our facilities and processes to ensure we comply with regulatory bodies like the US FDA.

MALAYSIA’S pharmaceutical industry relies heavily on the public sector, which buys around 70% of generic drugs in the market.

Duopharma Biotech Bhd reflects this trend, with half of its products supplied to the public sector, 42% to the private sector, and the remaining 8% exported.

Subscribe now and receive free sooka plan for 1 month. T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

To trust or not to trust?
Is your office building up to code?
Solar panels: Are they worth it?
Malaysia garnered over RM8bil in potential investments at Expo 2025 Osaka, says Fadillah
Ringgit expected to trade in cautious mode next week amid US tariff uncertainty
LBS RECORDS ROBUST GROWTH
China opens commodity gates
Keep critical national agendas going despite�ministers’ exit
Master craftsman speaks visual language
Cautious optimism in Philippine stocks

Others Also Read


OSZAR »